DGAT1 and prostate carcinoma: DGAT1, ABHD5, and ATGL are overexpressed in prostate cancer cells compared to peripheral blood mononuclear cells, and inhibition of DGAT1 and ABHD5 was found to lead to prostate cancer cell death (107).